Human amnion-derived mesenchymal stem cells are a potential source for uterine stem cell therapy

Cell Proliferation

Volumn 41, Issue 5, 2008, Pages 709-725

  Han, K ^a   Lee, J E ^a   Kwon, S J ^a   Park, S Y ^a   Shim, S H ^b   Kim, H ^c   Moon, J H ^d   Suh, C S ^d   Lim, H J ^a,e  

^a Konkuk University   (South Korea)

^b CHA University   (South Korea)

^c Seoul Women University   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; CD31 ANTIGEN; CD45 ANTIGEN; CD59 ANTIGEN; ENDOGLIN; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; PROGESTERONE RECEPTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR HOXA10; VASCULAR CELL ADHESION MOLECULE 1; WNT5A PROTEIN;

ADULT; AMNION CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; KARYOTYPE; LENTIVIRINAE; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; UTERUS;

AMNION; ANIMALS; CYTOGENETIC ANALYSIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEODOMAIN PROTEINS; HUMANS; INTERFERON TYPE II; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS; RECEPTORS, PROGESTERONE; TIME FACTORS; TISSUE THERAPY; UTERUS; WNT PROTEINS;

LENTIVIRUS; MUS;

EID: 51649088249     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2008.00553.x     Document Type: Article

References (51)

1. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP (2007) Term Amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev. Biol. 7, 11.
2. Anjos-Afonso F, Siapati EK, Bonnet D (2004) In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci. 117, 5655 5664.
3. 1 cell cycle phase. J. Cell. Physiol. 209, 883 893.
4. Becker-Hapak M, McAllister SS, Dowdy SF (2001) TAT-mediated protein transduction into mammalian cells. Methods 24, 247 256.
5. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL (1996) Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 122, 2687 2696.
6. Bjornsson JM, Andersson E, Lundstrom P, Larsson N, Xu X, Repetowska E, Humphries RK, Karlsson S (2001) Proliferation of primitive myeloid progenitors can be reversibly induced by HOXA10. Blood 98, 3301 3308.
7. Chan J, O'Donoghue K, de la Fuente J, Roberts IA, Kumar S, Morgan JE, Fisk NM (2005) Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23, 93 102.
8. Chang CJ, Yen ML, Chen YC, Chien CC, Huang HI, Bai CH, Yen BL (2006) Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 24, 2466 2477.
9. Clements MO, Godfrey A, Crossley J, Wilson SJ, Takeuchi Y, Boshoff C (2006) Lentiviral manipulation of gene expression in human adult and embryonic stem cells. Tissue Eng. 12, 1741 1751.
10. De Coppi P, Bartsch G Jr., Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25, 100 106.
11. Drukker M, Benvenisty N (2004) The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 22, 136 141.
12. Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99, 9864 9869.
13. Du H, Taylor HS (2007) Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 25, 2082 2086.
14. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J (2005) Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106, 4057 4065.
15. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K (2004) Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22, 649 658.
16. Gargett CE (2004) Stem cells in gynaecology. Aust. N. Z. J. Obstet. Gynaecol. 44, 380 386.
17. Girardi G, Bulla R., Salmon JE, Tedesco F (2006) The complement system in the pathophysiology of pregnancy. Mol. Immunol. 43, 68 77.
18. Gregory CA, Prockop DJ, Spees JL (2005a) Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp. Cell Res. 306, 330 335.
19. Gregory CA, Ylostalo J, Prockop DJ (2005b) Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental 'niches' in culture: a two-stage hypothesis for regulation of MSC fate. Sci. STKE 2005, pe37.
20. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM (2007) Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25, 646 654.
21. Han K, Song H, Moon I, Augustin R, Moley K, Rogers M, Lim H (2007) Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis. J. Endocrinol. 192, 539 551.
22. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, Fibbe WE, Kanhai HH (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102, 1548 1549.
23. 1/S transition in mouse embryonic stem cells. Oncogene 21, 5515 5528.
24. Joliot A, Prochiantz A (2004) Transduction peptides: from technology to physiology. Nat. Cell Biol. 6, 189 196.
25. Kim J, Kang HM, Kim H, Kim MR, Kwon HC, Gye MC, Kang SG, Yang HS, You J (2007a) Ex vivo characteristics of human amniotic membrane-derived stem cells. Cloning Stem Cells 9, 581 594.
26. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, Cho DJ, Kang SG, You J (2007b) Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 40, 75 90.
27. Kmita M, Duboule D (2003) Organizing axes in time and space; 25 years of colinear tinkering. Science 301, 331 333.
28. Koumas L, King AE, Critchley HO, Kelly RW, Phipps RP (2001) Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. Am. J. Pathol. 159, 925 935.
29. Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, Sauvageau G, Humphries RK, Largman C (2005) Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 106, 3988 3994.
30. Le Blanc K, Tammik C, Rosenthal K, Zetterberg E, Ringden O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31, 890 896.
31. Lim H, Ma L, Ma WG, Maas RL, Dey SK (1999) Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol. Endocrinol. 13, 1005 1017.
32. Ma L, Benson GV, Lim H, Dey SK, Maas RL (1998) Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev. Biol. 197, 141 154.
33. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS, Platt JL (1995) Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. 1, 423 427.
34. Mericskay M, Kitajewski J, Sassoon D (2004) Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 131, 2061 2072.
35. Miki T, Lehmann T, Cai H, Stolz. DB, Strom SC (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23, 1549 1559.
36. Mimeault M, Batra SK (2006) Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 24, 2319 2345.
37. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150 8157.
38. Morris MC, Vidal P, Chaloin L, Heitz F, Divita G (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25, 2730 2736.
39. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4, 1449 1452.
40. Nagy A, Gertsenstein M, Vintersten K, Behringer R (2003) Manipulation the Mouse Embryo. New York : Cold Spring Harbor Laboratory Press.
41. Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7, 354 359.
42. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143 147.
43. Ryan JM, Barry FP, Murphy JM, Mahon BP (2005) Mesenchymal stem cells avoid allogeneic rejection. J. Inflamm. (Lond.) 2, 8.
44. + subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA 91, 12223 12227.
45. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP (2007) Stem cell transplantation: the lung barrier. Transplant. Proc. 39, 573 576.
46. Taylor HS (2004) Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 292, 81 85.
47. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz. MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145 1147.
48. Tsai MS, Lee JL, Chang YJ, Hwang SM (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum. Reprod. 19, 1450 1456.
49. Uccelli A, Pistoia V, Moretta L (2007) Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28, 219 226.
50. Van Damme A, Thorrez L, Ma L, Vandenburgh H, Eyckmans J, Dell'Accio F, De BC, Luyten F, Lillicrap D, Collen D, Vandendriessche T, Chuah MK (2006) Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 24, 896 907.
51. Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T (2005) Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79, 528 535.